Clinical Trials Browser

Approved for marketing × INDUSTRY × avelumab × Clear all

NCT03089658 2019-10-09

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Approved for marketing

Carcinoma, Merkel Cell